Share on Facebook
Share on Twitter
Share on LinkedIn

MUMBAI, July 3 (Reuters) – India’s Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the U.S. Food and Drug Administration said on Thursday.

The drug being recalled was manufactured by Sun Pharma’s unit Caraco Pharmaceutical Laboratories Ltd at its plant in the western Indian state of Gujarat, the FDA said in a post on its website.

Click here to read more.